Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) Expects to Submit European Union Marketing Application in H2 for Epidiolex in Dravet Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 29, 2017
Occurred Source:
https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-submits-marketing-authorisation-application-europe-epidiolex%C2%AE
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Union, Marketing Application, Epidiolex, Dravet Syndrome
